News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
INNOVENT BIO Soars 6%+ as It Records First Annual Profit of RMB814M
INNOVENT BIO (01801.HK) achieved its first annual profit, spurring its stock price today (27th) with an initial rise of 0.88% at the open bell, peaking at HKD85.55. It last posted ...
Reset
Send
The window will close in 5 seconds
INNOVENT BIO Soars 6%+ as It Records First Annual Profit of RMB814M
Close
Recommend
1
Positive
5
Negative
4
 
 

INNOVENT BIO (01801.HK)  +0.600 (+0.660%)    Short selling $398.18M; Ratio 95.618%   achieved its first annual profit, spurring its stock price today (27th) with an initial rise of 0.88% at the open bell, peaking at HKD85.55. It last posted at HKD84.7, up 6.68%, with a trading volume of 10.698 million shares, involving HKD890 million.

INNOVENT BIO turned from loss to profit last year, earning RMB814 million, with revenue of RMB13.042 billion, marking a 38.4% YoY increase. On non-IFRS measures, the profit reached RMB1.723 billion.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Related News CMBI Slightly Raises TP for INNOVENT BIO (01801.HK) to HKD113.86, Accelerating Global Biopharmaceutical Transformation



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.